BioELife Corp.
LITH
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 800.00 | -- |
| Gross Profit | -- | -- | -- | -800.00 | -- |
| SG&A Expenses | 19.60K | 21.70K | 26.00K | 21.40K | 16.70K |
| Depreciation & Amortization | 1.20K | 300.00 | 0.00 | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.80K | 21.90K | 26.10K | 22.20K | 16.70K |
| Operating Income | -20.80K | -21.90K | -26.10K | -22.20K | -16.70K |
| Income Before Tax | -48.40K | -106.20K | 80.30K | -515.40K | 37.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.40K | -106.20K | 80.30K | -515.40K | 37.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.40K | -106.20K | 80.30K | -515.40K | 37.70K |
| EBIT | -20.80K | -21.90K | -26.10K | -22.20K | -16.70K |
| EBITDA | -19.60K | -21.70K | -26.00K | -- | -- |
| EPS Basic | -0.01 | -0.04 | 0.03 | -0.20 | 0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| EPS Diluted | -0.01 | -0.04 | 0.03 | -0.20 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 |
| Average Basic Shares Outstanding | 4.76M | 2.67M | 2.63M | 2.63M | 2.63M |
| Average Diluted Shares Outstanding | 4.76M | 2.67M | 2.63M | 2.63M | 2.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |